No fountain of youth: FDA and NIH review off-label use of hormones.
Hanna
Kathi E
KE
D017277:Drug Approval; D004348:Drug Labeling; D004967:Estrogens / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D020249:Hormone Replacement Therapy / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008593:Menopause / Q000187:drug effects; D009316:National Institutes of Health (U.S.); D011372:Progestins / Q000009:adverse effects / Q000627:therapeutic use; D013739:Testosterone / Q000008:administration & dosage / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration; D016387:Women's Health
D004967:Estrogens; D011372:Progestins; D013739:Testosterone